DNA sequencing uncovers latent risk for developing cystic fibrosis
Monday, July 25, 2016 - 17:31
in Health & Medicine
A study by researchers at Children's Hospital Los Angeles (CHLA), Brigham and Women's Hospital and the California Department of Public Health suggests that all babies with a known mutation for cystic fibrosis (CF) and second mutation called the 5T allele should receive additional screening in order to better predict the risk of developing CF later in life.